Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: A cross-sectional study

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Yang, Shuyu ^a,b   Xiao, Fangsen ^b   Pan, Lingling ^c   Zhang, Huijie ^b   Ma, Zhimin ^d   Liu, Suhuan ^a   Liu, Yongwen ^b   Zhang, Wei ^a   Zeng, Xin ^a   Liu, Changqin ^b   Li, Xiaoying ^a,b,c   Li, Xuejun ^a,b   Li, Zhibin ^a,b  

^a Xiamen Diabetes Institute   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Body composition; Chronic kidney disease; Cross sectional study; Epidemiology; Irisin

Indexed keywords

CYTOKINE; IRISIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BODY BUILD; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CHINA; CHINESE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMMUNITY LIVING; CONFOUNDING VARIABLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; IRISIN BLOOD LEVEL; LIFESTYLE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; SOCIOECONOMICS; WAIST CIRCUMFERENCE; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BODY MASS; COMORBIDITY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; KIDNEY FUNCTION TEST; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; ODDS RATIO; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SEX RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BODY COMPOSITION; BODY MASS INDEX; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 84927712828     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0009-5     Document Type: Article

References (33)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives- a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247-59.
2. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379:165-80.
3. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158-69.
4. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, et al. Chronic kidney disease prognosis consortium. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis BMJ. 2013;346:f324. doi:10.1136/bmj.f324.
5. Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24:1205-12.
6. Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, et al. Prevalence and factors associated with CKD: a population study in Beijing. Am J Kidney Dis. 2008;51:373-84.
7. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815-22.
8. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
9. Alicic RZ, Patakoti R, Tuttle KR. Direct and indirect effects of obesity on the kidney. Adv Chronic Kidney Dis. 2013;20:121-7.
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
11. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 2012;10:138.
12. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-8.
13. Kelly DP. Medicine. Irisin, light my fire. Science. 2012;336:42-3.
14. Huh JY, Panagiotou G, Mougious V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in human: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725-38.
15. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:365-9.
16. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96-101.
17. Moreno-Navarrete JM, Ortega F, Serrano M. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769-78.
18. Wen MS, Wang CY, Lin SL, Hung KC. Decrease in irisin in patients with chronic kidney disease. PLoS ONE. 2013;8:e64025.
19. Liu JJ, Liu S, Wong MD, Tan CS, Tavintharan S, Sum CF, et al. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications. 2014;28:208-13.
20. Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, et al. Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol. 2014;170:501-6.
21. Kahn HS, Bullard KM, Barker LE, Imperatore G. Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS ONE. 2012;7:e50428.
22. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;8:555-63.
23. Schooling CM, Lam TH, Li ZB, Ho SY, Chan WM, Ho KS, et al. Obesity, physical exercise and mortality in a prospective Chinese elderly cohort: a fallacy explained. Arch Intern Med. 2006;166:1498-504.
24. Raschke S, Eckel J. Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm. 2013;2013:320724. doi: 10.1155/2013/320724.
25. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belén Crujeiras A, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE. 2013;8:e60563.
26. Yan B, Shi X, Zhang H, Pan L, Ma Z, Liu S, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS ONE. 2014;9:e94235.
27. Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013;59:557-62.
28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
29. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937-44.
30. Kong X, Ma Y, Chen J, Luo Q, Yu X, Li Y, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant. 2013;28:641-51.
31. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
32. Irving BA, Still CD, Argyropoulos G. Does IRISIN have a BRITE future as a therapeutic agent in humans. Curr Obes Rep. 2014;3:235-41.
33. Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens. 2008;17:450-6.